Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Depreciation and Depletion (2016 - 2025)

Historic Depreciation and Depletion for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to $425000.0.

  • Harvard Bioscience's Depreciation and Depletion fell 274.6% to $425000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 362.02%. This contributed to the annual value of $1.7 million for FY2024, which is 1513.33% up from last year.
  • Per Harvard Bioscience's latest filing, its Depreciation and Depletion stood at $425000.0 for Q3 2025, which was down 274.6% from $411000.0 recorded in Q2 2025.
  • In the past 5 years, Harvard Bioscience's Depreciation and Depletion ranged from a high of $470000.0 in Q4 2021 and a low of $331000.0 during Q4 2022
  • In the last 5 years, Harvard Bioscience's Depreciation and Depletion had a median value of $418000.0 in 2023 and averaged $407789.5.
  • In the last 5 years, Harvard Bioscience's Depreciation and Depletion crashed by 2957.45% in 2022 and then soared by 2861.45% in 2024.
  • Over the past 5 years, Harvard Bioscience's Depreciation and Depletion (Quarter) stood at $470000.0 in 2021, then fell by 29.57% to $331000.0 in 2022, then rose by 25.98% to $417000.0 in 2023, then grew by 10.07% to $459000.0 in 2024, then dropped by 7.41% to $425000.0 in 2025.
  • Its Depreciation and Depletion was $425000.0 in Q3 2025, compared to $411000.0 in Q2 2025 and $451000.0 in Q1 2025.